This case is of interest because a carcinoma has developed at a relatively young age in association with a new but increasingly popular treatment in the form of in vitro fertilization. We have found no previously reported case.
Case report
In March 1987 a 34-year-old Caucasian started a programme of in vitro fertilization (lVF). She had been unable to conceive following salpingitis at 18 years causing tubal adhesions. In the past she had taken the combined oral contraceptive pill for nine years and there was no family history of breast carcinoma. She underwent two treatments with IVF in March and July 1987, receiving clomiphene citrate for five days and injections of follicle stimulating hormone (FSH). Pregnancy was not achieved on either occasion. However, she did notice that her breasts became enlarged and tender for six to eight weeks following each treatment attempt.
In September she became aware of a lump in the left breast associated with pain. This was examined two weeks later and found to be a 3 em irregular mass in the outer quadrant. No lymph nodes were palpable. A wide excision was performed and the histology showed it to be a poorly differentiated infiltrating duct carcinoma with little stroma. Ligand binding assays for oestrogen and progesterone receptors were negative.
A further attempt at IVF was cancelled and she was referred for radiotherapy. Liver screening and a technetium bone scan were negative although it was noted that there was an increased uptake of technetium in both breasts.
Discussion
Breast carcinoma can be hormone dependent and the very high levels of oestrogen associated with IVF may have influenced the development of our patient's tumour. However, caution is necessary with this theory for the following reasons.
The association between breast carcinoma and the hormone changes of pregnancy have been studied. Some studies show a more aggressive type of tumour with an increase of metastatic disease'. In other studies pregnancy did not seem to directly affect the prognosis". However, it was found that the majority of cases, as in our patient, were receptor negative. This is associated with a worse prognosis" and may indicate hormone insensitivity. It has been found that very high oestradiol levels may cause some ligand binding assays to be falsely negative, and in this patient an immunochemical technique for receptors may have been more accurate.
The oestrogen levels can be raised 10-fold during IVF but this is usually for a short time. Our patient did notice changes in her breasts for six to eight weeks following treatment, which may have been in response to changing hormone levels.
It should be taken into account that breast carcinoma in this age group is unusual but not rare. This, combined with the increasing number of women entered for IVF programmes (3717 in the UK during 1985 4 ) make a coincidental association more likely.
In addition this patient has two known risk factors for developing breast carcinoma, nulliparity and prolonged use of the oral contraceptive pill prior to pregnancy6.
The technique associated with IVF seems unlikely to be a primary aetiological factor in this patient's breast carcinoma. However, further reports of such cases would make an association more suspicious.
